Jung Ho Cha
Overview
Explore the profile of Jung Ho Cha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheon K, Chung Y, Cho H, Kim M, Cha J, Kang C, et al.
J Clin Endocrinol Metab
. 2018 Jun;
103(9):3376-3385.
PMID: 29947765
Context: Müllerian-inhibiting substance/anti-Müllerian hormone (MIS/AMH) is produced in the ovarian granulosa cells, and it is believed to inhibit ovarian folliculogenesis and steroidogenesis in women of reproductive age. Objective: To investigate...
2.
Song J, Jo H, Kim M, Lew Y, Ryu K, Cha J, et al.
Int J Oncol
. 2012 Feb;
40(6):2013-21.
PMID: 22344630
This study aimed to analyze expression of Müllerian inhibiting substance type II receptor (MISRII) protein and mRNA in cervical neoplasia, to demonstrate the growth inhibition of cervical cancer cells by...
3.
Song J, Chen K, Kim S, Kim M, Ryu K, Cha J, et al.
Int J Oncol
. 2009 May;
34(6):1583-91.
PMID: 19424576
This study investigated the expression patterns of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor (MIS/AMHRII) and mRNA in various types of ovarian neoplasia and evaluated the clinical significance of MIS/AMH...
4.
Infiltration of nestin-expressing cells in interstitial fibrosis in chronic cyclosporine nephropathy
Ahn K, Li C, Lim S, Song H, Ghee J, Kim S, et al.
Transplantation
. 2008 Aug;
86(4):571-7.
PMID: 18724228
Background: Nestin-expressing cells play a role in the repair process of injured tissues and organs. This study examined the nestin-expressing cells in interstitial fibrosis in experimental chronic cyclosporine A (CsA)...
5.
Li C, Lim S, Choi B, Lee S, Cha J, Kim I, et al.
Am J Nephrol
. 2005 Nov;
25(6):611-20.
PMID: 16308546
Background/aims: Overexpression of transforming growth factor beta1-inducible gene h3 (betaig-h3) is associated with renal scarring in several models of renal disease. We investigated the inhibitory effect of pravastatin on betaig-h3...
6.
Li C, Sun B, Lim S, Song J, Kang S, Kim Y, et al.
Transplantation
. 2005 Jun;
79(11):1522-9.
PMID: 15940041
Background: Statins and angiotensin II type I receptor blockers have synergistic effects on vascular smooth-muscle-cell proliferation and the progression of renal diseases. We evaluated whether combined treatment with losartan (LSRT)...
7.
Li C, Yang C, Park C, Ahn H, Kim W, Yoon K, et al.
Kidney Int
. 2003 Mar;
63(2):454-63.
PMID: 12631111
Background: Osteopontin (OPN) mediates progressive renal injury in various renal diseases by attracting macrophages, and its expression is regulated by the renin-angiotensin system (RAS). We studied the association between OPN...
8.
Yang C, Ahn H, Kim W, Li C, Jung J, Yoon S, et al.
Transplantation
. 2003 Feb;
75(3):309-15.
PMID: 12589150
Background: Combined treatments of mycophenolate mofetil (MMF) and losartan (LSRT) have synergistic effects on various renal diseases through their hemodynamic and anti-inflammatory effects. This study investigated whether MMF treatment is...
9.
Li C, Yang C, Kim W, Jung J, Cha J, Kim Y, et al.
Am J Physiol Renal Physiol
. 2003 Jan;
284(2):F389-98.
PMID: 12529276
Renal interstitial inflammation is an important factor in the pathogenesis of chronic cyclosporin A (CsA) nephropathy. We studied the expression of the chemoattractant osteopontin (OPN) and the relationship between OPN...
10.
Yang C, Lee S, Lim S, Jung J, Kim W, Kim H, et al.
Nephron
. 2002 Oct;
92(4):914-21.
PMID: 12399639
Background: Epidermal growth factor (EGF) plays an important role in tubular regeneration in kidneys with ischemia/reperfusion (I/R) injury. This study was undertaken to evaluate the influence of cyclosporine A (CsA)...